Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
By Donald J Benton, Steven Gamblin & Antoni Wrobel
Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro
By Susha Cheriyedath
Pfizer's novel COVID-19 antiviral heads to clinical trials
By Bethany Halford